How many drugs were approved in 1996?

Drug Landscape tracks 64 drug approvals with a first_approval_date in 1996 (FDA, EMA, MHRA, PMDA combined). The full list is on this page, each linked to its primary regulatory source.

Which patents expired in 1996?

No tracked patents have an expiry date in 1996.

What Phase 3 readouts happened in 1996?

No Phase 3 trials have completion dates in 1996.

Where does this data come from?

Approvals from FDA Drugs@FDA, EMA EPAR, MHRA, and PMDA. Patent data from FDA Orange Book + USPTO PAIR. Trial data from ClinicalTrials.gov. Updates daily.

1996 in pharma — approvals, patent cliffs, Phase 3 readouts

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 1996: 64 approvals, 0 patent expiries, 0 Phase 3 milestones.

1994 1995 1996 1997 1998

FDA / EMA / MHRA approvals (64)

1996-06-14 — Remeron · Generic (originally Organon/MSD) · United States · Neuroscience
1996-07-25 — Allegra · Generic (originally Hoechst Marion Roussel/Sanofi) · United States · Metabolic
1996-12-17 — Lipitor · Pfizer Inc. · United States · Metabolic
1996-12-20 — Levaquin · Generic (originally Daiichi Sankyo/J&J) · United States · Infectious Disease
1997 — Omnicef · Infectious Disease
1997 — FERRIC AMMONIUM CITRATE
1997 — Aldara · Bausch Health · Oncology
1997 — CLOPIDOGREL BISULFATE
1997 — ROPINIROLE HYDROCHLORIDE
1997 — TIAGABINE HYDROCHLORIDE
1997 — LETROZOLE
1997 — Skelid · Bone
1997 — Tomefloxacin · Otsuka · Infectious Disease
1997 — Zomig · AstraZeneca · Metabolic
1997 — MANGAFODIPIR · Gastroenterology
1997 — Anzemet · Validus Pharms · Other
1997 — Prandin · Novo Nordisk · Metabolic
1997 — RITUXIMAB
1997 — Mabthera · Roche · Oncology
1997 — Zenapax · Hoffman-La Roche · Immunology
1997 — ALATROFLOXACIN MESYLATE
1997 — Mabthera · Roche · Oncology
1997 — TROVAFLOXACIN
1997 — BROMFENAC SODIUM
1997 — Posicor · Cardiovascular
1997 — Evista · Eli Lilly · Oncology
1997 — Hair-X Hair Loss Relief · Chattem · Immunology
1997 — Gabitril · Cephalon · Neuroscience
1997 — Agrylin · Takeda · Oncology
1997 — ARDEPARIN SODIUM
1997 — Mabthera · Roche · Oncology
1997 — Neorecormon · Roche Registration Limited · Oncology
1997 — Emadine · Novartis · Immunology
1997 — CERIVASTATIN SODIUM
1997 — INTERFERON ALFACON-1
1997 — TROVAFLOXACIN MESYLATE
1997 — Rezulin · Pfizer · Metabolic
1997 — PRAMIPEXOLE
1997 — Viracept · Agouron Pharms · Immunology
1997 — Racemic Sibutramine · Metabolic
1997 — Genesa · Cardiovascular
1997 — STREPTOKINASE · Hematology
1997 — Avapro · Sanofi · Metabolic
1997 — Baycol · Bayer · Metabolic
1997 — REPAGLINIDE
1997 — ALBUMIN HUMAN
1997 — Edronax · Neuroscience
1997 — Antizol · Par Pharm Inc · Metabolic
1997 — Fareston · Kyowa Kirin · Oncology
1997 — Manganese Chloride In Plastic Container · Pfizer · Other
1997 — Regranex · Omj Pharmaceuticals · Metabolic
1997 — Avapro · Sanofi · Metabolic
1997 — EPROSARTAN MESYLATE
1997 — Rescriptor · GSK · Immunology
1997 — Corlopam · Pfizer · Cardiovascular
1997 — Teveten · AbbVie · Metabolic
1997 — Pytest · Avent · Other
1997 — Imodium Multi-Symptom Relief · Mcneil · Dermatology
1997 — ALATROFLOXACIN · Pfizer · Infectious Disease
1997 — RALOXIFENE HYDROCHLORIDE
1997 — Sclerosol · Nobelpharma Co., Ltd. · Infectious Disease
1997 — BORDETELLA PERTUSSIS PERTACTIN AUTOTRANSPORTER
1997 — BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ
1997 — Pandel · ANI Pharmaceuticals · Immunology

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.